Introduction
Many patients express difficulty in swallowing tablets and hard gelatin capsules, resulting in noncompliance and ineffective therapy (1) .Thus difficulty is particularly experienced by pediatric and geriatric patients. Different approaches are used for development of fast dissolving tablets such as using superdisintegrants namely croscarmellose sodium,crospovidone and sodium starch glycolate. Another approach, maximaizes the porous structure of tablet by sublimation method .Vacuum drying has been used to form porous structure of tablets (2) (3) .Ketorolac tromethamine is a non steroidal anti-inflammatory drug commonly used to decrease post operative pain associated with surgical treatment (4) Ketorolac tromethamine is found to be as effective as morphine for postoperative pain in children with fewer side effects (5) .
II. Materials and methods

Materials
Ketorolac tromethamine was obtained from Elamrya Pharmacutical Ind-Egypt.All other chemicals of analytical grade were purchased from commercial sources. (6) . The medicated tablets were prepared by first gentle triturating using mortar The ingredients were weighed and mixed in geometrical order and compressed into tablets of weight 100 mg using 6mm round flat punches on 10 station rotary tablet machine( Single punch tablet press Erweka type-Germany ). A batch of 100 tablets of each formulation was prepared for all the designed formulations. The dose of ketorolac tromethamine was 10 mg, in each tablet. (8) (9) . It is the ratio of total mass of powder to the tapped volume of the powder. It can be calculated from the following equation and expressed also in g/ml. It is determined by transferring the weighed amount of the blend 5gm to the graduated cylinder (10 ml) with the aid of a funnel. The blend is tapped for a fixed time, the tapped volume (V t ) is recorded .
2.2Preparation of ketorolac tromethamine tablets
Micromeretic properties of physical mixtures
D t = M/V t Where M is the mass of the powder and V t is the tapped volume of the powder. ( 
Angle of repose (θ)
10)
The friction forces in a loose powder can be measured by the angle of repose. It is defined as maximum angle possible between the surface of the pile of powder and horizontal plane. The powder is allowed to flow freely through a cut stem funnel which height was adjusted in such a way that the tip of the funnel just touched the apex of the heap of the powder. The diameter of the powder cone is measured and its angle of repose can be calculated using following equation :
tan (θ) = h / r (θ) = tan -1 (h / r) Where (ɵ) is the angle of repose, h is the height in cms and r is the radius in cms 2.3.4.. Compressibility Index (Carr's Index) and Hausner's ratio (11) : The compressibility index (Carr's Index) and Hausner's ratio of all the prepared powder blends were determined from their bulk density and tapped density values as follows:
Tapped density Hausner's ratio = Tapped density/ Bulk density
2.3.5
Particle size determination The particle size study was performed to ensure homogeneity and uniformity of each drug-excipient blend. The particle size of all the prepared powder blends was recorded using Horiba Laser scattering particle size distribution analyzer-model LA-920. Japan.
Evaluation of ketorolac tromethamine fast dissolving tablets 2.4.1.Weight variation
The individual weights of twenty tablets selected randomly from each formulation were reported and the average weight and standard deviations were calculated (12) .
2.4.2Tablet hardness
Six accidentally selected tablets from each formulation were tested for tablet hardness measurement using Erweka hardness tester -Heusenstamm-Gernany. The results were calculated as the mean hardness in (Kp) (13) (14) . (15) . Ten tablets were randomly selected from each formulation and pulverized to a fine powder. A quantity of powder equivalent to a single dose was weighed and assayed for the drug content using a UV visible spectrophotometer (Shimadzu model UV-2450-Japan) at wavelength 322 nm .
Content uniformity
Tablet friability
Pre-weighed sample of tablets (six tablets from each batch) was placed in the drum of the friabilator (Erweka type, GmbH-Germany), and rotated for 100 revolutions (25 rpm for 4 min).Tablets were dusted and reweighed. The percent loss in the weight was calculated and, taken as a measure of friability (16) (17) . The friability % was calculated from the following equation (18) (19) :
% Friability= [(Initial weight of tablets-final weight of tablets) ×100] initial weight of tablets
In vitro disintegration time (21)
It was determined using disintegration test apparatus ( Pharmatest type,PTZ3-West Germany). A tablet was placed in each of six tubes of the apparatus and one disc was added to each tube .The time in seconds taken for complete disintegration of the tablet was recorded. (21) . Twice folded tissue papers were placed in a petri dish of 5 cm diameter. Six ml of water were added to the petri dish. A tablet was carefully placed on the surface of the tissue paper.The time required for water to reach the upper surface of the tablet and to completely wet it was noted as the wetting time.
Wetting time
In-vitro release of the prepared fast dissolving ketorolac tromethamine tablets
The release study of ketorolac tromethamine from the prepared tablets was carried out using USP standard dissolution apparatus II ( Hanson Research, SR8 plus-USA) containing 500 ml of distilled deionized water as a dissolution medium ( Paddle method). Sample (5 ml) were collected at predetermined time intervals (1,2,3,4,5,6,7,8,9,10 min) and replaced with equal volume of fresh medium, filtered through 0.45 μ m membrane filter disc , and analyzed with a UV visible spectrophotometer (Shimadzu model UV-2450) at λ max 322 .
2.5.
Investigation of physicochemical compatibility of the used excipients with the drug 2.5.
Differential scanning calorimetry (DSC)
The thermal behavior of the selected formulae G2, G5, G9 and pure ketorolac tromethaine drug was investigated using differential scanning calorimeter (Shimadzu-DSC-50. Japan). The instrument was first calibrated with purified indium (99.99%).Samples of (2-4 mg) of each formula as well as the pure drug were heated under nitrogen atmosphere as a carrier gas on an aluminium pan at a flow rate of 25 ml/min and a heating rate of 10˚C/ min over a temperature range of 20-400˚C.
Fourier transform infra red spectroscopy (FTIR)
Infrared spectra of all the prepared formulae and pure ketorolac tromethamine were recorded using Fourier transform IR spectrophotometer ( Shimadzu, IR-435, U-04-Japan).
Stability study
Fast dissolving tablets of formulae G2, G5, and G9 were stored in well-closed amber glass vials at ambient conditions (on the shelf) for 12 months and under accelerated conditions of a temperature of 40 ˚C and 75% relative humidity for three months (22) (23) . The tablets were visually inspected for any physical changes and their friability, disintegration time and dissolution behaviors were compared before and after storage.
III.
Results and discussions
Micromeretic properties of physical mixtures of ketorolac tromethamine with different excipients .
In the present study, twelve ketorolac tomethamine fast dissolving tablets were prepared by direct compression method as shown in table (1) . Croscarmellose sodiume, crospovidone and sodium starch glycolate were used as superdisintegrants in four different concentrations (3%, 6%,9% and 12%). Avicel® PH102 was used as a binder due to its excellent compatibility at low pressures and high dilution potential, being also chemically inert and compatible with most drugs (24) (25) . Micromeretic properties of the prepared physical mixtures of ketorolac tromethamine showed good compressibility and flowability behavior as indicated from their compressibility index, angle of repose and Hausner's ratio. These results were in agreement with standard requirements of USP as shown in table (2) . Also, uniformity of particle size of the drug-excipient blends signified good homogeneity and uniformity during mixing and granulation processes as shown in figure (1) .
All the prepared tablets had acceptable hardness in the range from (3.133 ± 0.404 Kp) to (5.967 ± 0.764 Kp) as graphically represented in figure (2) . All the prepared tablets are with acceptable friability less than 1% as shown in figure (3) . Tablets prepared with the superdisintegrant croscarmellose sodium had the shortest disintegration and wetting times followed by those prepared with crospovidone and finally those prepared with sodium starch glycolate which had the longest disintegration and wetting times as illustrated graphically in figures (4&5).
The release of the drug from the prepared fast dissolving tablets was better than that from the conventional commercial tablets Fam® as shown in figures (6) (7) (8) . All the prepared tablets with different superdisintegrantes showed 75% release of the drug within the first 5 minutes while only 27.474 % of the drug was released from commercial tablets. Formulae G2, and G5 released 100 % of the drug within 4 and 3 minutes respectively. Increasing the concentration of crospovidone as a superdisintegrant had no significant effect on the dissolution profile of the tablets On the other hand, the change in concentration of both the superdisintegrants sodium starch glycolate and croscarmellose sodium had significant effect on the dissolution profile of their tablets. The selected excipients used, mannitol and Avicel PH 102, had a great effect on enhancing dissolution of the drug from the prepared tablets.
The physical mixtures of ketorolac tromethamine with the different used excipients of the selected tablet formulae (G2, G5 and G9) showed no physical or chemical interactions as detected from their DSC thermograms, and FTIR spectra, shown in figures (9& 10 ) .
The stability studies showed a significant change in the dissolution profile of the drug from the tablets of formulae G2, and G9 when stored under both ambient and accelerated conditions as shown in figures (11 & 12) . Therefore, Tablets of formula G5 (containing 3% corscarmellose sodium as superdisintegrant, 30% Avicel PH102, 5% aspartame , 1% talc , 1% magnesium stearate, and mannitol Q.S.) could be considered as the best selected formulation to prepare KT fast dissolving tablets , since they showed no significant change in the dissolution profile and its physicochemical characters upon storage under both ambient and accelerated conditions. Components  G1  2   G1  1   G10  G9  G8  G7  G6  G5  G4  G3  G2  G1   10  10  10  10  10  10  10  10  10  10  10  10  Ketorolac  tromethamine (KT)  --------12  9  6  3 Crospovidone ( CP ) 
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